C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter II—Drug Enforcement Administration, Department of JusticePart 1301—Registration of Manufacturers, Distributors, And Dispensers of Controlled Substances

21 C.F.R. § 1301.11 (2026)

Persons required to register; requirement of modification of registration authorizing activity as an online pharmacy

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 ACTIVE · 6 IN 5Y cited 1994–2025 20citing cases
At a glance

Courts have cited this section in 20 opinions since 1994, 6 of them in the last five years. The most litigated part is subsection (a) (1 case).

(a) Every person who manufactures, distributes, dispenses, imports, or exports any controlled substance or who proposes to engage in the manufacture, distribution, dispensing, importation or exportation of any controlled substance shall obtain a registration unless exempted by law or pursuant to §§ 1301.22 through 1301.26. Except as provided in paragraph (d) of this section, only persons actually engaged in such activities are required to obtain a registration; related or affiliated persons who are not engaged in such activities are not required to be registered. (For example, a stockholder or parent corporation of a corporation manufacturing controlled substances is not required to obtain a registration.)

(b) Practitioners who dispense narcotic drugs (other than narcotic drugs in schedule III, IV, or V) to individuals for maintenance treatment or detoxification treatment shall obtain annually a separate registration for that purpose.

(c) As a condition on registration under this part and section 303 of the Act (21 U.S.C. 823) to dispense controlled substances in schedule II, III, IV, or V, qualified practitioners, as defined in § 1300.01 of this chapter, must meet the training requirements set forth in section 303(m) of the Act (21 U.S.C. 823(m)). No qualified practitioner is required to complete the training more than once. This requirement applies from the first registration or renewal of registration by a qualified practitioner that occurs on or after June 27, 2023.

(d) As provided in sections 303(f) and 401(h) of the Act (21 U.S.C. 823(f) and 841(h)), it is unlawful for any person who falls within the definition of “online pharmacy” (as set forth in section 102(52) of the Act (21 U.S.C. 802(52)) and § 1300.04(h) of this chapter) to deliver, distribute, or dispense a controlled substance by means of the internet if such person is not validly registered with a modification of such registration authorizing such activity (unless such person is exempt from such modified registration requirement under the Act or this chapter). The Act further provides that the Administrator may only issue such modification of registration to a person who is registered as a pharmacy under section 303(f) of the Act (21 U.S.C. 823(f)). Accordingly, any pharmacy registered pursuant to § 1301.13 that falls within the definition of an online pharmacy and proposes to dispense controlled substances by means of the internet must obtain a modification of its registration authorizing such activity following the submission of an application in accordance with § 1301.19. This requirement does not apply to a registered pharmacy that does not fall within the definition of an online pharmacy set forth in § 1300.04(h) of this chapter. Under the Act, persons other than registered pharmacies are not eligible to obtain such a modification of registration but remain liable under section 401(h) of the Act (21 U.S.C. 841(h)) if they deliver, distribute, or dispense a controlled substance while acting as an online pharmacy without being validly registered with a modification authorizing such activity.

[91 FR 34767, June 9, 2026]
The 20 cases that cite 21 C.F.R. § 1301.11 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENWalters v. UPMC Presbyterian Shadyside, 187 A.3d 214 (Pa. 2018).
cites § 1301.11 1×cited by 37 cases
Where it cites § 1301.11
“§ 822 (a) ; 21 C.F.R. § 1301.11 (a). Pennsylvania law, too, requires UPMC, but not Maxim, to register.”
The case’s holding
A hospital subject to federal reporting regulations owes a common-law duty to report known diversion of controlled substances to law enforcement to prevent harm to third parties.
Later courts cite it for
“the fact that the actor realizes that action on his part is necessary for another's aid or protection does not of itself impose upon him a duty to take such action.” · 3 citing courts
2
GREENCardinal Health, Inc. v. Holder, 846 F. Supp. 2d 203 (D.D.C. 2012).
cites § 1301.11 1×cited by 22 cases
Where it cites § 1301.11
“§ 822 ; 21 C.F.R. § 1301.11 . Distributors of Schedule I or Schedule II drugs — controlled substances with a “high potential for abuse,” 21 U.”
Later courts cite it for
“has reason to believe that a registrant's continued operation would pose 'an imminent danger to the public health or safety.” · 2 citing courts
3
GREENBeinor v. Indus. Claim Appeals Off., 262 P.3d 970 (Colo. Ct. App. 2011).
cites § 1301.11 1×cited by 19 cases
Where it cites § 1301.11
“That document specifies that "[t]his assessment is not a prescription for the use of marijuana" (emphasis added).”
Later courts cite it for
“a physician does not prescribe marijuana, but may only provide 'written documentation' stating that the patient has a debilitating medical condition and might benefit from the medical use of marijuana.” · 3 citing courts
4
GREENHoliday CVS, L.L.C. v. Holder, 839 F. Supp. 2d 145 (D.D.C. 2012).
cites § 1301.11 1×cited by 13 cases
Where it cites § 1301.11
“§ 822 ; 21 C.F.R. § 1301.11 . Under the DEA’s regulations, registered pharmacies must “provide effective controls and procedures to guard against theft and diversion of controlled substances.”
5
GREENAdibi v. California State Bd. of Pharmacy, 393 F. Supp. 2d 999 (N.D. Cal. 2005).
cites § 1301.11 2×cited by 3 cases
Where it cites § 1301.11
“(2) Failing to obtain a DEA registration to dispense and export dangerous drugs, a violation of 21 C.F.R. § 1301.11 (a), thereby violating California Business & Professions Code § 4059.”
Later courts cite it for
“for younger abstention, the adequacy of the opportunity to litigate the federal claim in a state proceeding requires that such opportunity be timely - i.e., prior to the administrative deprivation.” · 2 citing courts
6
GREENMorris & Dickson Co. v. Whitaker, 360 F. Supp. 3d 434 (W.D. La. 2018).
cites § 1301.11 1×cited by 3 cases
Where it cites § 1301.11
“§ 822 (a)(1) ; 21 C.F.R. § 1301.11 (a). When evaluating a distributor's application, the DEA considers whether the registration is "inconsistent with the public interest" in light of the following factors: (1) maintenance of effective control against diversion of particular…”
Later courts cite it for
“there is no reason to conclude that any strength of plaintiff's appointment clause challenge on the basis of lucia alters the question of jurisdiction.” · 2 citing courts
7
GREENUnited States v. Anderson, 271 F. Supp. 3d 950 (M.D. Tenn. 2017).
cites § 1301.11 1×cited by 2 cases
Where it cites § 1301.11
“” 21 C.F.R. § 1301.11 (a). “Dispense” is defined in the CS4 as to deliver a controlled substance to an ultimate user by, or pursuant to the lawful order of, a practitioner.”
8
GREENHolden v. Comm'r, 110 T.C.M. 53 (T.C. 2015).
cites § 1301.11 2×cited by 1 caseunpublished
Where it cites § 1301.11
“11 (2009) , and we conclude that the second October 29 expense served this purpose.”
9
NEUTRALGreen Collar Club v. State, 413 P.3d 1083 (Wash. Ct. App. 2018).
cites § 1301.11 1×cited by 3 cases
Summary
No passage or summary on file for this case yet.
10
NEUTRALAm. Med. Ass'n v. Reno, 857 F. Supp. 80 (D.D.C. 1994).
cites § 1301.11 2×cited by 1 case
Where it cites § 1301.11
“15272 (1993) (codified at 21 C.F.R. §§ 1301.11 ). Specifically, plaintiffs contend that the DEA violated the Administrative Procedure Act (“APA”), 5 U.”
cites § 1301.11 2×cited by 0 cases
Summary
No passage or summary on file for this case yet.
12
NO FLAGCom. v. Scott, D., No. 464 MDA 2016 (Pa. Super. Ct. Apr. 11, 2017).
cites § 1301.11 1×cited by 0 casesunpublished
Where it cites § 1301.11
“21 C.F.R. § 1301.11 (d)(37). Schedule I drugs can only be dispensed for government-approved research projects.”
13
NO FLAGRainier Xpress v. State Of Washington, No. 50437-5 (Wash. Ct. App. Mar. 27, 2018).
cites § 1301.11 1×cited by 0 cases
Summary
No passage or summary on file for this case yet.
14
NO FLAGVirtus Pharm., LLC v. Garland, No. 2021-2308 (D.D.C. Sept. 22, 2021).
cites § 1301.11 1×cited by 0 cases
Where it cites § 1301.11
“§§ 821 , 822; 21 C.F.R. § 1301.11 . Entities not properly registered with the DEA under the CSA may not manufacture, distribute, or dispense controlled substances.”
cites § 1301.11 1×subsections: (a)cited by 0 cases
Where it cites § 1301.11
“§ 822 (a)(1); 21 C.F.R §§ 1301.11(a), 1301.12(a). DEA establishes annual production quotas for lawful mari- juana cultivation, and it has exercised that authority by setting the annual quotas for the National Center, the only entity ever registered by DEA to grow marijuana to…”
16
GREENIn re Cardinal Health, Inc. Derivative Litig., 518 F. Supp. 3d 1046 (S.D. Ohio 2021).
cites § 1301.11 1×cited by 0 casesunknown
Summary
No passage or summary on file for this case yet.
17
NO FLAGCity of Huntington v. AmerisourceBergen Drug Corp., No. 3:17-cv-01362 (S.D. W. Va. Feb. 15, 2022).
cites § 1301.11 1×cited by 0 casesunknown
Where it cites § 1301.11
“(including, but not limited to, 21 C.F.R. §§ 1301.11 , 1301.74), 21 C.F.R.”
18
NO FLAGVirtus Pharm., LLC v. Garland, No. 2022-0448 (D.D.C. Mar. 26, 2025).
cites § 1301.11 1×cited by 0 cases
Where it cites § 1301.11
“§§ 821 , 822; 21 C.F.R. § 1301.11 . Entities not properly registered with the DEA under the CSA may not manufacture, distribute, or dispense controlled substances.”
19
GREENSualeh Ashraf v. United States Drug Enf't Admin., 153 F.4th 1161 (11th Cir. 2025).
cites § 1301.11 1×cited by 0 cases
Where it cites § 1301.11
“Ashraf’s responsibilities in- cluded maintaining a COR under the Controlled Substances Act (“CSA”), 21 C.F.R. § 1301.11 , in order to dispense controlled sub- stances from the Clinic.”
Later courts cite it for
“the agency relied on factors not intended by congress, ignored an important aspect of the issue, or offered an explanation that contradicts the evidence before it.” · 2 citing courts
20
NO FLAGUnited States v. Pecina, 302 F.R.D. 492 (N.D. Ind. 2014).
cites § 1301.11 1×cited by 0 cases
Where it cites § 1301.11
“is duly registered with the Drug Enforcement Administration pursuant to 21 C.F.R. § 1301.11 et seq. Forensic Analytical Sciences, Inc.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
199420092025

One bar per year. Tallest: 5 cases in 2018. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D.D.C.5Wash. Ct. App.211th Cir.1N.D. Cal.1Colo. Ct. App.1Del. Ch.1N.D. Ind.1W.D. La.1

The 8 courts with the most citing cases, of 15 courts in all.

By subsection
(a)1 case
Licensing Marijuana Cultivation in Compliance with the Single Convention on Narcotic Drugs (OLC 2018).“§ 822 (a)(1); 21 C.F.R §§ 1301.11(a), 1301.12(a). DEA establishes annual production quotas for lawful mari- juana cultivation, and it has exercised that authority by setting the annual quotas for the National Center, the only entity ever registered by DEA to grow marijuana to…”
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com